Drugs / AXS-07
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03896009 | Mar → Dec 2019 | migraine disorder | Axsome Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AXS-07 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03896009 ↗ |
| Route | Oral | “AXS-07 is an oral, investigational medicine” NCT03896009 ↗ |